Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

ASEAN Aromatherapy Industry Valuation Set to Total USD 1,127.5 Million by 2034 Amid Growing Consumer Interest in Natural Remedies | FMI
Healthcare & PharmaceuticalCompany Update

ASEAN Aromatherapy Industry Valuation Set to Total USD 1,127.5 Million by 2034 Amid Growing Consumer Interest in Natural Remedies | FMI

November 5, 2024 9:00 PM

As per Future Market Insights' latest analysis, the aromatherapy industry analysis in ASEAN value is set to total USD 575.1 million in 2024 and USD 1,127.5 million by 2034. Demand for aromatherapy products in ASEAN is forecast to increase at 7.2% CAGR throughout the assessment period.Several factors are anticipated to fuel growth of the aromatherapy industry in ASEAN over the next ten years. These include rising consumer interest in natural...

Read more
Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing
Healthcare & PharmaceuticalCompany Update

Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing

November 5, 2024 5:20 PM

Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, has been facing a series of challenges that has hindered its ability to both operate as well as meet its financial obligations. This serves as an update to Juva's shareholders regarding recent developments...

Read more
Nonprofit Partners With Newark Black Churches To Bridge Health Disparities
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Nonprofit Partners With Newark Black Churches To Bridge Health Disparities

November 5, 2024 4:45 PM

By Amira Sweilem | NJ Advance Media for NJ.comOriginally published by NJ Advance Media on Mosaic.NJ.comNORTHAMPTON, MA / ACCESSWIRE / November 5, 2024 / "A lot of the reasons why people died at alarming rates within Black and brown communities was due to pre-existing conditions," said the Rev. Kimberly L. Williams, Choose Healthy Life's executive director.Mike Prevoznik agreed."We saw the disproportionate impact that COVID had on underserved...

Read more
NHI Announces Retirement of W. Andrew Adams from the Board of Directors
Healthcare & PharmaceuticalCompany Update

NHI Announces Retirement of W. Andrew Adams from the Board of Directors

November 5, 2024 4:15 PM

National Health Investors, Inc. (NYSE:NHI) announced today that after more than 30 years of leadership, W. Andrew "Andy" Adams has notified the Board of Directors of National Health Investors, Inc. that he plans to retire as Chairman of the Board effective December 31, 2024.Andy Adams founded the Company in 1991 and has served as Chairman since inception. He served as both President and Chief Executive Officer since the founding and until his...

Read more
NHI Issues Investor Update
Healthcare & PharmaceuticalCompany Update

NHI Issues Investor Update

November 5, 2024 4:10 PM

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update which can be found at: NHI | Presentations and Webcasts (nhireit.com).Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and...

Read more
NHI Announces Fourth Quarter 2024 Dividend
Healthcare & PharmaceuticalDividends

NHI Announces Fourth Quarter 2024 Dividend

November 5, 2024 4:10 PM

MURFREESBORO, TN / ACCESSWIRE / November 5, 2024 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay its fourth quarter dividend of $0.90 per common share on January 29, 2025 to stockholders of record as of December 31, 2024.About NHIIncorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships,...

Read more
Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting
Healthcare & PharmaceuticalConferences

Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting

November 5, 2024 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that final data from the Phase 2 REVIVE study with rusfertide in polycythemia vera will be the focus of a poster presentation at the 66th Annual American Society of Hematology (ASH) Annual Meeting being held in San Diego from December 7-10, 2024.ASH Presentation Details:Presenting author: Aaron Gerds, MD (Cleveland Clinic)Publication Number: 4559Title: Final Results from...

Read more
NHI Announces Third Quarter 2024 Results
Healthcare & PharmaceuticalEarnings

NHI Announces Third Quarter 2024 Results

November 5, 2024 4:05 PM

National Health Investors, Inc. (NYSE:NHI) announced today its results for the three and nine months ended September 30, 2024.Financial Results and Recent EventsNet income attributable to common stockholders per diluted common share for the three months ended September 30, 2024 was $0.65 compared to $0.68 during the same period in the prior year. Net income attributable to common stockholders per diluted common share for the nine months ended...

Read more
CannapharmaRx to Complete Additional Shipment in November
Healthcare & PharmaceuticalCompany Update

CannapharmaRx to Complete Additional Shipment in November

November 5, 2024 1:20 PM

CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in cutting-edge, highly efficient cannabis production, is pleased to announce continued progress at its Cremona, Alberta facility, where cannabis cultivation remains on track according to the company's annual plan. Following the resignation of CEO Dean Medwid in early September, the company has been able to maintain uninterrupted operations while fulfilling and delivering its orders.Recent...

Read more
Formula Wellness Recognizes Christopher P. Crosby as Chief Financial Officer
Healthcare & PharmaceuticalCompany Update

Formula Wellness Recognizes Christopher P. Crosby as Chief Financial Officer

November 5, 2024 11:30 AM

Formula Wellness, a leader in personalized wellness and aesthetics services, recognizes Christopher P. Crosby as Chief Financial Officer. Christopher joins the company with 17 years of comprehensive experience in finance, investment, and portfolio management. He will oversee the company's financial strategy while guiding Formula Wellness toward sustainable growth, patient expansion, and a technology-enhanced wellness platform.With this strategic...

Read more
Purivitae Ventures, an Oakland Capital Partners, LLC Company Acquires CoreMasters and Masteryourcore.com, Welcoming New Leadership
Healthcare & PharmaceuticalCompany Update

Purivitae Ventures, an Oakland Capital Partners, LLC Company Acquires CoreMasters and Masteryourcore.com, Welcoming New Leadership

November 5, 2024 11:00 AM

Purivitae Ventures is pleased to announce the acquisition of CoreMasters, a leading name in the fitness industry, along with the popular website Masteryourcore.com, which has been integrated as FitnessHardware.com. This strategic acquisition is a significant step forward in Purivitae's mission to enhance its portfolio of innovative fitness solutions and expand its reach in the health and wellness market.Tim Austin, President of Purivitae...

Read more
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
Healthcare & PharmaceuticalDividends

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

November 5, 2024 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S. in Communications from Santa Clara University and an MBA from the Northwestern University Kellogg School of Management. As she served in her last position as UTMD's manager of Global Direct End User Sales, the...

Read more
Beebe Healthcare Partners With Sublimation Health and AWS for Fully Cloud-Based EHR Implementation and Long-Term Cloud Managed Services
Healthcare & PharmaceuticalCompany Update

Beebe Healthcare Partners With Sublimation Health and AWS for Fully Cloud-Based EHR Implementation and Long-Term Cloud Managed Services

November 5, 2024 9:45 AM

LEWES, DE / ACCESSWIRE / November 5, 2024 / Beebe Healthcare has partnered with Sublimation Health to transform its digital landscape with an Epic Electronic Health Record (EHR) system hosted on Amazon Web Services (AWS). This collaboration marks the latest zero-on-premises, public-cloud healthcare ecosystem implementation, allowing Beebe to leverage cloud-based solutions for greater security and operational efficiency.Sublimation Health brings...

Read more
Cantargia Presents Promising Preclinical Results on Nadunolimab With Antibody-Drug Conjugates at Major Immuno-Oncology Conference
Healthcare & PharmaceuticalCompany Update

Cantargia Presents Promising Preclinical Results on Nadunolimab With Antibody-Drug Conjugates at Major Immuno-Oncology Conference

November 5, 2024 9:15 AM

LUND, SWEDEN / ACCESSWIRE / November 05, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported preclinical results on potential synergism between nadunolimab and antibody-drug conjugate (ADC) therapies. The new findings show that ADCs, just like chemotherapy, induce both tumor promoting as well as neuropathy inducing signals that can be counteracted by nadunolimab. Results will be presented in a poster...

Read more
Vheda Health Awarded Centene's Partnership Purpose Award
Healthcare & PharmaceuticalAwards

Vheda Health Awarded Centene's Partnership Purpose Award

November 5, 2024 9:00 AM

Award Recognizes Vheda Health's Commitment to Excellence in Transforming Health Outcomes for Centene's Underserved PopulationsCOLUMBIA, MD. / ACCESSWIRE / November 5, 2024 / Vheda Health, a leader in virtual health engagement, is honored to announce that it has been awarded Centene's prestigious Partnership Purpose Award. The award, presented during Centene's Enterprise Procurement with Purpose Summit, recognizes Vheda Health for its exemplary...

Read more
AMC Health Receives Expanded FDA Clearance for Advanced Virtual Care and Risk Prediction Technology
Healthcare & PharmaceuticalCompany Update

AMC Health Receives Expanded FDA Clearance for Advanced Virtual Care and Risk Prediction Technology

November 5, 2024 9:00 AM

Predicated on an unrivaled trove of millions of data points amassed over 20 years, these AI tools accurately predict near-term risk of ED, all-cause hospitalization, or death sans mitigation.NEW YORK, NY / ACCESSWIRE / November 5, 2024 / AMC Health is proud to announce that its virtual care and clinical decision support solution has received its third FDA 510(k) clearance, recognized as a Class II software medical device. This new clearance...

Read more
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
Healthcare & PharmaceuticalCompany Update

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

November 5, 2024 8:12 AM

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today that on November 4, 2024 it closed its previously announced private placement pursuant to a purchase agreement (the "Purchase Agreement") for the purchase and sale of an aggregate of 1,948,295 shares of common stock, series A common stock purchase warrants to purchase an aggregate of 1,948,295 shares...

Read more
Tangerine Retreat in the Netherlands Offers a New Path to Mental Health and Wellness
Healthcare & PharmaceuticalProduct Announcements

Tangerine Retreat in the Netherlands Offers a New Path to Mental Health and Wellness

November 5, 2024 7:15 AM

Tangerine Retreat, a newly established retreat center in the Netherlands, is leading the way in the mental health crisis movement by offering a legal and supportive space for those looking to find relief from mental health challenges through magic mushroom retreat. Tangerine Retreat is the first psychedelic retreat center created by a United Kingdom resident, aims to create a safe haven for guided psilocybin experiences. The retreat offers...

Read more
The Future Of Healthcare Is Here: Introducing Medibay
Healthcare & PharmaceuticalCompany Update

The Future Of Healthcare Is Here: Introducing Medibay

November 5, 2024 7:05 AM

Forte Healthcare, a UAE-based healthcare service provider and regional operator, is leading an exciting new chapter in the healthcare industry by pioneering MediBAY, an AI-driven clinic set to redefine primary care delivery. Forte Healthcare operates as an incubator for forward-thinking healthcare solutions, and MediBAY is the latest initiative working towards accelerating the advancement of healthcare delivery. Designed for efficiency and...

Read more
ESSE Care Opens a Boutique Clinic in Greenwich, Expanding the Wellness and Complementary Medicine Capacity
Healthcare & PharmaceuticalCompany Update

ESSE Care Opens a Boutique Clinic in Greenwich, Expanding the Wellness and Complementary Medicine Capacity

November 5, 2024 7:00 AM

Just a short train ride from Manhattan or a scenic drive along the Merritt Parkway, visitors can find ESSE Care's new location at Exit 31 on North Street, set amidst the serene backdrop of back-country Greenwich.GREENWICH, CT / ACCESSWIRE / November 5, 2024 / ESSE Care and Wellness LLC, a premier endometriosis and reproductive health clinic, is excited to announce its expanded facility at 779 North Street. Led by Dr. Goldstein, the clinic offers...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?